Abstract
Objectives: Our objectives are (i) to determine whether an increase in competition among companies selling prescription anti-ulcer pharmaceuticals has an impact on drug costs for Ohio Medicaid; (ii) to separate competition’s impact into its effect on generic drugs and its effect on branded drugs; and (iii) to distinguish between inter-drug (market) and intra-drug (generic) competition in their effects on drug-prescription reimbursements and utilisation.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
